Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
27.08
+1.53 (5.99%)
Dec 6, 2024, 4:00 PM EST - Market closed
Spyre Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 71.58 | 188.89 | 34.86 | 15.14 | 90.1 | 19.25 | Upgrade
|
Short-Term Investments | 342.65 | 150.38 | 20.85 | 77.99 | 56.18 | 52.7 | Upgrade
|
Cash & Short-Term Investments | 414.23 | 339.28 | 55.71 | 93.13 | 146.27 | 71.95 | Upgrade
|
Cash Growth | 103.45% | 508.99% | -40.18% | -36.33% | 103.30% | -3.44% | Upgrade
|
Other Receivables | 1.7 | - | 0.38 | 0.82 | - | - | Upgrade
|
Receivables | 1.7 | - | 0.38 | 0.82 | - | - | Upgrade
|
Prepaid Expenses | 5.15 | 2.25 | 6.17 | 4.95 | 3.52 | 2.56 | Upgrade
|
Total Current Assets | 421.08 | 341.53 | 62.26 | 98.89 | 149.79 | 74.51 | Upgrade
|
Property, Plant & Equipment | - | - | 7.25 | 9.15 | 9.94 | 7.17 | Upgrade
|
Other Long-Term Assets | 0.01 | 0.33 | 1.64 | 1.88 | 1.89 | 1.51 | Upgrade
|
Total Assets | 421.09 | 341.86 | 71.14 | 109.93 | 161.62 | 83.18 | Upgrade
|
Accounts Payable | 5.17 | 0.9 | 0.68 | 3.32 | 2.25 | 3.15 | Upgrade
|
Accrued Expenses | 14.65 | 29.69 | 12.82 | 13.25 | 13.41 | 14.39 | Upgrade
|
Current Portion of Leases | - | - | 0.64 | 0.85 | 0.35 | 0.38 | Upgrade
|
Current Unearned Revenue | - | - | 0.52 | 2.36 | - | - | Upgrade
|
Other Current Liabilities | 37.72 | 1.39 | - | 0.37 | 0.44 | 0.44 | Upgrade
|
Total Current Liabilities | 57.54 | 31.98 | 14.66 | 20.14 | 16.44 | 18.36 | Upgrade
|
Long-Term Leases | - | - | 4 | 4.62 | 5.17 | 4.74 | Upgrade
|
Long-Term Unearned Revenue | - | - | 2.18 | 1.22 | - | - | Upgrade
|
Other Long-Term Liabilities | 36.16 | 125.87 | - | - | 0.17 | - | Upgrade
|
Total Liabilities | 93.7 | 157.84 | 20.84 | 25.99 | 21.79 | 23.1 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
Additional Paid-In Capital | 1,086 | 763.19 | 475.97 | 425.77 | 415.82 | 255.14 | Upgrade
|
Retained Earnings | -916.14 | -764.41 | -425.62 | -341.81 | -276.01 | -195.12 | Upgrade
|
Comprehensive Income & Other | 1.46 | 0.3 | -0.05 | -0.02 | 0.01 | 0.05 | Upgrade
|
Total Common Equity | 171.57 | -0.91 | 50.31 | 83.94 | 139.83 | 60.08 | Upgrade
|
Shareholders' Equity | 327.39 | 184.02 | 50.31 | 83.94 | 139.83 | 60.08 | Upgrade
|
Total Liabilities & Equity | 421.09 | 341.86 | 71.14 | 109.93 | 161.62 | 83.18 | Upgrade
|
Total Debt | - | - | 4.65 | 5.48 | 5.52 | 5.12 | Upgrade
|
Net Cash (Debt) | 414.23 | 339.28 | 51.07 | 87.65 | 140.75 | 66.83 | Upgrade
|
Net Cash Growth | 103.45% | 564.39% | -41.74% | -37.73% | 110.62% | -10.31% | Upgrade
|
Net Cash Per Share | 11.16 | 49.19 | 15.15 | 33.33 | 65.93 | 52.29 | Upgrade
|
Filing Date Shares Outstanding | 51.43 | 36.15 | 2.62 | 1.97 | 1.92 | 1.16 | Upgrade
|
Total Common Shares Outstanding | 51.4 | 36.06 | 2.61 | 1.97 | 1.92 | 1.16 | Upgrade
|
Working Capital | 363.54 | 309.55 | 47.6 | 78.75 | 133.35 | 56.15 | Upgrade
|
Book Value Per Share | 3.34 | -0.03 | 19.24 | 42.52 | 72.89 | 51.64 | Upgrade
|
Tangible Book Value | 171.57 | -0.91 | 50.31 | 83.94 | 139.83 | 60.08 | Upgrade
|
Tangible Book Value Per Share | 3.34 | -0.03 | 19.24 | 42.52 | 72.89 | 51.64 | Upgrade
|
Machinery | - | - | 2.85 | 2.82 | 2.72 | 1.53 | Upgrade
|
Leasehold Improvements | - | - | 4.39 | 4.39 | 4.77 | 1.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.